Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of tofacitinib on JAK-STAT pathway activity in rheumatoid arthritis
2017-002753-11Phase 4Completed
- Sponsor
- Tampere University Hospital
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tofacitinib in rheumatoid arthritis (RA), sponsored by Tampere University Hospital. Primary endpoint: Change in STAT protein activity. Started Nov 2017; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2017-002753-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002753-11.